Alwyn Mwinga

Director/Board Member at Drugs for Neglected Diseases initiative

Consumer Services

Health Technology

Profile

Alwyn Mwinga is currently the Director at Drugs for Neglected Diseases initiative.
She has a graduate degree from the University of London and a graduate degree from the University of Zambia.

Alwyn Mwinga active positions

Companies	Position	Start
Drugs for Neglected Diseases initiative Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.	Director/Board Member	-

All active positions of Alwyn Mwinga

Training of Alwyn Mwinga

University of London	Graduate Degree
University of Zambia	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alwyn Mwinga's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Drugs for Neglected Diseases initiative Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland.	Health Technology